Literature DB >> 26271024

Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors.

Sagar R Shroff1, Vladimir M Kushnir, Sachin B Wani, Neil Gupta, Sreenivasa S Jonnalagadda, Faris Murad, Dayna S Early, Daniel K Mullady, Steven A Edmundowicz, Riad R Azar.   

Abstract

BACKGROUND: Endoscopic mucosal resection (EMR) for small (<20 mm) duodenal neuroendocrine tumors (NETs) remains controversial because of their rarity.
MATERIALS AND METHODS: This is a retrospective cohort study of patients with surgically or endoscopically resected duodenal NETs from 2001 to 2011. The primary outcome is the rate of disease-free status following resection. A secondary outcome is the sensitivity of endoscopic ultrasound (EUS) in determining NET appropriateness for EMR.
RESULTS: Thirty patients underwent resection of duodenal NETs (EMR 20, surgery 10). Tumor was present at the margins in 40% of EMR-resected NETs and 10% of surgically resected NETs. Five patients who underwent EMR had residual disease treated with repeat EMR (3) and surgery (2). EUS demonstrated 96% sensitivity in determining lesions limited to the submucosa.
CONCLUSIONS: EMR for small duodenal NETs can be a safe and effective alternative to surgery in carefully selected patients. EUS is a useful adjunct in determining depth of invasion for duodenal NETs.

Entities:  

Mesh:

Year:  2015        PMID: 26271024     DOI: 10.1097/SLE.0000000000000192

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  4 in total

1.  Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection.

Authors:  Catherine G Tran; Scott K Sherman; Mohammed O Suraju; Apoorve Nayyar; Henning Gerke; Rami G El Abiad; Chandrikha Chandrasekharan; Po Hien Ear; Thomas M O'Dorisio; Joseph S Dillon; Andrew M Bellizzi; James R Howe
Journal:  Ann Surg Oncol       Date:  2021-09-13       Impact factor: 5.344

2.  The Number of Lymph Nodes Examined is Associated with Survival Outcomes of Neuroendocrine Tumors of the Jejunum and Ileum (siNET): Development and Validation of a Prognostic Model Based on SEER Database.

Authors:  Peng Wang; Erlin Chen; Mingjie Xie; Wei Xu; Chaoyang Ou; Zhou Zhou; Yuanjie Niu; Wei Song; Qingfeng Ni; Jianwei Zhu
Journal:  J Gastrointest Surg       Date:  2022-06-10       Impact factor: 3.267

3.  A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.

Authors:  Georgios Antonios Margonis; Mario Samaha; Yuhree Kim; Lauren McLendon Postlewait; Pamela Kunz; Shishir Maithel; Thuy Tran; Nickolas Berger; T Clark Gamblin; Matthew G Mullen; Todd W Bauer; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2016-03-23       Impact factor: 3.452

4.  Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.

Authors:  Bobby V M Dasari; Sarah Al-Shakhshir; Timothy M Pawlik; Tahir Shah; Ravi Marudanayagam; Robert P Sutcliffe; Darius F Mirza; Paolo Muiesan; Keith J Roberts; John Isaac
Journal:  J Gastrointest Surg       Date:  2018-06-04       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.